Orphan drug Kalydeco now available in Wales

The much-celebrated orphan drug Kalydeco (ivacaftor) will be made available to the estimated 13 eligible patients with cystic fibrosis in Wales, confirmed Mark Drakeford, Welsh Assembly Minister for Health and Social Services, last Friday (May 10th). Not only will this be great news for the manufacturers, Vertex, but it's also great news for patients and those who campaigned for the …